株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の潜伏結核感染(LTBI)検査市場:考察、動向、予測

Global Latent Tuberculosis Infection (LTBI) Testing Market Report: Insights, Trends & Forecast (2019-2023)

発行 Koncept Analytics 商品コード 891094
出版日 ページ情報 英文 106 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.43円で換算しております。
Back to Top
世界の潜伏結核感染(LTBI)検査市場:考察、動向、予測 Global Latent Tuberculosis Infection (LTBI) Testing Market Report: Insights, Trends & Forecast (2019-2023)
出版日: 2019年07月18日 ページ情報: 英文 106 Pages
概要

当レポートでは、世界の潜伏結核感染(LTBI)検査市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 市場概要

第2章 世界の潜伏結核感染(LTBI)検査市場

  • 価値別市場予測
  • 地域別市場価値
  • 売上高別市場予測
  • 地域別市場売上高
  • セグメント別市場売上高

第3章 地域別潜伏結核感染(LTBI)検査市場

  • 米国
  • 中国
  • アジア太平洋地域(日本と中国を除く)
  • ラテンアメリカ
  • 日本
  • 欧州・中東

第4章 市場動向

  • 成長促進因子
    • 結核に対する意識向上
    • 高齢化
    • タバコ価格の低下
    • 結核検出率の上昇
    • タバコ消費の拡大
    • 都市人口の増加
    • HIVの罹患率上昇
  • 主な動向と発展
    • 政府の取り組み
    • 新興市場における医療費高騰
    • 先進型ハイブリッド技術の拡大
    • LPA
    • NAAT
  • 課題
    • 厳しい政府の規制
    • 多剤耐性結核
    • 新興市場における意識の不足
    • 試験所施設の不足

第6章 競合環境

  • 世界市場

第7章 企業プロファイル

  • Qiagen
  • Abbott
  • Becton Dickinson
  • BioMerieux
  • Roche Holding AG
  • Thermo Fisher Scientific Inc
目次

The global latent tuberculosis infection (LTBI) testing market is estimated to reach US$2.1 billion in 2023, growing at a CAGR of 5.59% for the period spanning from 2018 to 2023. The factors such as rapid tuberculosis prevalence, increased tuberculosis awareness, rising prevalence of HIV and increasing government initiatives are expected to drive the market growth. However, growth of the industry will be challenged by multidrug resistant tuberculosis, lack of laboratory facilities and lack of awareness in emerging markets. A few notable trends include increasing government initiatives, increasing healthcare expenditure in emerging countries and advanced and hybrid technologies.

The latent tuberculosis infection testing market comprises two main segments namely Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA). TST being a traditional test for tuberculosis diagnosis is the most recommended test. In the global latent tuberculosis testing market, the tuberculin skin test segment accounted for the higher share in 2018.

The fastest growing regional market is the U.S. due to increasing public awareness and increasing healthcare expenditure on diagnosis and treatment in developing countries. The U.S. represents one of the largest market for LTBI testing and is already well-penetrated at developed market levels. China, Japan and Europe and Middle East are emerging markets where growth lies in government expenditure on disease related initiatives and technological developments.

Scope of the report:

The report provides a comprehensive analysis of the global latent tuberculosis infection (LTBI) testing market, segmented into Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA) segments.

The major regional markets (Europe and Middle East, Asia Pacific (Excluding Japan and China) and Latin America) have been analyzed, along with country coverage of US, China and Japan.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Qiagen, Abbott, Becton Dickinson, Biomerieux, Roche and Thermo Fisher Scientific) are also presented in detail.

Key Target Audience:

Latent Tuberculosis Infection (LTBI) Testing Devices Manufacturers

Raw Material/Component Suppliers

End Users (Physician Offices, Hospitals, Healthcare Clinics)

Consulting Firms

Investment Banks

Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Tuberculosis (TB)
  • 1.2 Types of Tuberculosis (TB)
  • 1.3 Latent Tuberculosis Infection (LTBI)
  • 1.4 Risk Factors of Latent Tuberculosis
  • 1.5 Types of Latent Tuberculosis Infection Testing
  • 1.6 Latent Tuberculosis Infection Testing Segmentation

2. Global LTBI Testing Market

  • 2.1 Global LTBI Testing Market Forecast by Value
  • 2.2 Global LTBI Testing Market Value by Region
  • 2.3 Global LTBI Testing Market Forecast by Volume
  • 2.4 Global LTBI Testing Market Volume by Region
  • 2.5 Global LTBI Testing Market Volume by Segment
    • 2.5.1 Global IGRA Testing Market Forecast by Volume
    • 2.5.2 Global TST Market Forecast by Volume

3. Regional LTBI Testing Market

  • 3.1 The U.S.
    • 3.1.1 The U.S. LTBI Testing Market Forecast by Value
    • 3.1.2 The U.S. LTBI Testing Market Forecast by Volume
    • 3.1.3 The U.S. LTBI Testing Market by End User
  • 3.2 China
    • 3.2.1 China LTBI Testing Market Forecast by Value
    • 3.2.2 China LTBI Testing Market Forecast by Volume
  • 3.3 Asia-Pacific (Excluding Japan and China)
    • 3.3.1 Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Value
    • 3.3.2 Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Volume
  • 3.4 Latin America
    • 3.4.1 Latin America LTBI Testing Market Forecast by Value
    • 3.4.2 Latin America LTBI Testing Market Forecast by Volume
  • 3.5 Japan
    • 3.5.1 Japan LTBI Testing Market Forecast by Value
    • 3.5.2 Japan LTBI Testing Market Forecast by Volume
  • 3.6 Europe and Middle East
    • 3.6.1 Europe and Middle East LTBI Testing Market Forecast by Value
    • 3.6.2 Europe and Middle East LTBI Testing Market Forecast by Volume

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Increasing Awareness of Tuberculosis
    • 4.1.2 Rising Geriatric Population
    • 4.1.3 Declining Tobacco Price
    • 4.1.4 Increasing Tuberculosis Detection Rate
    • 4.1.5 Upsurge in Cigarette Consumption
    • 4.1.6 Growing Urban Population
    • 4.1.7 Rising Prevalence of HIV
  • 4.2 Key Trends & Developments
    • 4.2.1 Increasing Government Initiatives
    • 4.2.2 Increasing Healthcare Expenditure in Emerging Markets
    • 4.2.3 Expansion of Advanced and Hybrid Technique
    • 4.2.4 Line Probe Assays (LPAs)
    • 4.2.5 Nucleic Acid Amplification Tests (NAATs)
  • 4.3 Challenges
    • 4.3.1 Stringent Government Regulations
    • 4.3.2 Multidrug Resistant Tuberculosis (MDR-TB)
    • 4.3.3 Lack of Awareness in Emerging market
    • 4.3.4 Lack of Laboratory Facilities

5. Competitive Landscape

  • 5.1 Global Market
    • 5.1.1 Revenue Comparison of Key Players
    • 5.1.2 Market Cap Comparison of Key Players
    • 5.1.3 R&D Comparison of Key Players

6. Company Profiles

  • 6.1 Qiagen
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Abbott
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Becton Dickinson
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 BioMerieux
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies
  • 6.5 Roche Holding AG
    • 6.5.1 Business Overview
    • 6.5.2 Financial Overview
    • 6.5.3 Business Strategies
  • 6.6 Thermo Fisher Scientific Inc
    • 6.6.1 Business Overview
    • 6.6.2 Financial Overview
    • 6.6.3 Business Strategies

List of Figures

  • Symptoms of TB
  • Types of TB
  • Differences between Latent TB and Active TB
  • Risk Factors of Latent Tuberculosis
  • Types of Latent Tuberculosis Infection Testing
  • Latent Tuberculosis Infection Testing Segmentation
  • Global LTBI Testing Market Forecast by Value (2018-2023)
  • Global LTBI Testing Market Value by Region (2018)
  • Global LTBI Testing Market Forecast by Volume (2018-2023)
  • Global LTBI Testing Market Volume by Region (2018)
  • Global LTBI Testing Market Volume by Segments (2018)
  • Global IGRA Test Market Forecast by Volume (2018-2023)
  • Global TST Market Forecast by Volume (2018-2023)
  • The U.S. LTBI Testing Market Forecast by Value (2018-2023)
  • The U.S. LTBI Testing Market Forecast by Volume (2018-2023)
  • The US LTBI Testing Market by End User (2018)
  • China LTBI Testing Market Forecast by Value (2018-2023)
  • China LTBI Testing Market Forecast by Volume (2018-2023)
  • Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Value (2018-2023)
  • Asia-Pacific (Excluding Japan and China) LTBI Testing Market Forecast by Volume (2018-2023)
  • Latin America LTBI Testing Market Forecast by Value (2018-2023)
  • Latin America LTBI Testing Market Forecast by Volume (2018-2023)
  • Japan LTBI Testing Market Forecast by Value (2018-2023)
  • Japan LTBI Testing Market Forecast by Volume (2018-2023)
  • Europe and Middle East LTBI Testing Market Forecast by Value (2018-2023)
  • Europe and Middle East Mark LTBI Testing Market Forecast by Volume (2018-2023)
  • Global Literacy Rate (2014-2018)
  • Global Geriatric Population (2014-2018)
  • Global Tobacco Price (2013-2021)
  • Global Tuberculosis Case Detection Rate (2014-2018)
  • Global Cigarette Consumption (2014-2020)
  • Global Urban Population (2014-2019)
  • Global HIV Population (2014-2018)
  • Global Healthcare Expenditure (1995-2022)
  • Revenue Comparison of Key Players (2018)
  • Market Cap Comparison of Key Players (2018)
  • R&D Comparison of Key Players (2017-2018)
  • Qiagen Net Sales and Net Income (2014-2018)
  • Qiagen Net Sales by Segment (2018)
  • Qiagen Net Sales by Region (2018)
  • Abbott Net Sales and Net Earnings (2014-2018)
  • Abbott Net Sales by Segment (2018)
  • Abbott Net Sales by Region (2018)
  • Becton Dickinson Revenue and Net Income (2014-2018)
  • Becton Dickinson Revenue by Segment (2018)
  • Becton Dickinson Revenue by Region (2018)
  • BioMerieux Sales and Net Income (2014-2018)
  • BioMerieux Sales by Segment (2018)
  • BioMerieux Sales by Region (2018)
  • Roche Holding AG Revenue and Net Income (2014-2018)
  • Roche Holding AG Revenue by Segment (2018)
  • Roche Holding AG Revenue by Region (2018)
  • Thermo Fisher Scientific Revenue and Net Income (2014-2018)
  • Thermo Fisher Scientific Revenue by Segment (2018)
  • Thermo Fisher Scientific Revenue by Region (2018)

List of Tables

  • Current LPA products and Associated Equipment
  • NAAT-based Technologies
Back to Top